China’s venture capital firm QS Capital has raised RMB 100-million ($14-million) debut fund that seeks to make early stage investments in biotechnology, medical equipment and new consumer themes in the Asian country.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
